Trials / Active Not Recruiting
Active Not RecruitingNCT05696470
Fusion Rates of 3D Printed Porous Titanium Cages in Three and Four Level ACDFs
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (estimated)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to assess fusion rates in 3 and 4 level ACDFs in patients implanted with DePuy Conduit 3D printed titanium cages supplemented with SKYLINE Anterior Cervical Plate System and 1 CC DBM. This will be a non-inferiority study, looking to show that Synthes Conduit 3D printed titanium cages fuse as well as cages.
Detailed description
This is a prospective, single arm study of clinical and radiological outcomes from anterior cervical discectomy and fusions for cervical spondylosis. 58 Patients undergoing 3 to 4 level ACDF procedures from C2-T1 will be enrolled. Patients will be implanted with DePuy Conduit Titanium ACDF cage (DePuy Synthes, Raynham, MA). A retrospective comparision group will be used. The retrospective group will include 58 consecutive patients undergoing 3-4 level ACDFs with milled allograft. This single-centered study will enroll up to 58 subjects, with subjects followed for 24 months post-surgery. All subjects enrolled in the study will be recruited from a pool of subjects eligible for three or four level anterior cervical fusion surgeries. The inclusion/exclusion criteria are listed below.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DePuy Synthes Conduit 3D printed titanium cages | DePuy Conduit 3D printed titanium cages supplemented with SKYLINE Anterior Cervical Plate System and 1 CC DBM |
Timeline
- Start date
- 2021-03-31
- Primary completion
- 2026-03-31
- Completion
- 2026-12-31
- First posted
- 2023-01-25
- Last updated
- 2025-06-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05696470. Inclusion in this directory is not an endorsement.